Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome

Imagem de Miniatura
Arquivos
art_MENDES_Healthcare_associated_infection_in_hematopoietic_stem_cell_transplantation_2012.PDF (252.2 KB)
Citações na Scopus
34
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
BASSO, Mariusa
Citação
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, v.16, n.6, p.E424-E428, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: The objective of this study was to analyze the incidence of and risk factors for healthcare-associated infections (HAI) among hematopoietic stem cell transplantation (HSCT) patients, and the impact of such infections on mortality during hospitalization. Methods: We conducted a 9-year (2001-2009) retrospective cohort study including patients submitted to HSCT at a reference center in Sao Paulo, Brazil. The incidence of HAI was calculated using days of neutropenia as the denominator. Data were analyzed using EpiInfo 3.5.1. Results: Over the 9-year period there were 429 neutropenic HSCT patients, with a total of 6816 days of neutropenia. Bloodstream infections (BSI) were the most frequent infection, presenting in 80 (18.6%) patients, with an incidence of 11.7 per 1000 days of neutropenia. Most bacteremia was due to Gram-negative bacteria: 43 (53.8%) cases were caused by Gram-negative species, while 33 (41.2%) were caused by Gram-positive species, and four (5%) by fungal species. Independent risk factors associated with HAI were prolonged neutropenia (odds ratio (OR) 1.07, 95% confidence interval (CI) 1.04-1.10) and duration of fever (OR 1.20, 95% CI 1.12-1.30). Risk factors associated with death in multivariate analyses were age (OR 1.02, 95% CI 1.01-1.43), being submitted to an allogeneic transplant (OR 3.08, 95% CI 1.68-5.56), a microbiologically documented infection (OR 2.96, 95% CI 1.87-4.6), invasive aspergillosis disease (OR 2.21, 95% CI 1.1-4.3), and acute leukemias (OR 2.24, 95% CI 1.3-3.6). Conclusions: BSI was the most frequent HAI, and there was a predominance of Gram-negative microorganisms. Independent risk factors associated with HAI were duration of neutropenia and fever, and the risk factors for a poor outcome were older age, type of transplant (allogeneic), the presence of a microbiologically documented infection, invasive aspergillosis, and acute leukemia. Further prospective studies with larger numbers of patients may confirm the role of these risk factors for a poor clinical outcome and death in this transplant population. (C) 2012 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Palavras-chave
Hematopoietic stem cell transplant infection, Healthcare-associated infection
URI
https://observatorio.fm.usp.br/handle/OPI/551
Referências
  1. Campos IR, 2008, INT J ANTIMICROB AG, V32, P119
  2. CARLISLE PS, 1993, INFECT CONT HOSP EP, V14, P320
  3. Chaberny IF, 2009, ANN HEMATOL, V88, P907, DOI 10.1007/s00277-008-0687-1
  4. Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638
  5. Cordonnier C, 2006, CLIN INFECT DIS, V42, P955, DOI 10.1086/500934
  6. Dettenkofer M, 2005, CLIN INFECT DIS, V40, P926, DOI 10.1086/428046
  7. Dettenkofer M, 2003, BONE MARROW TRANSPL, V31, P795, DOI 10.1038/sj.bmt.1703920
  8. Engelhart S, 2002, INFECT CONT HOSP EP, V23, P244, DOI 10.1086/502043
  9. Engels EA, 1999, CLIN INFECT DIS, V28, P256, DOI 10.1086/515103
  10. Gudiol C, 2010, 50 INT C ANT AG CHEM
  11. Kara O, 2010, 50 INT C ANT AG CHEM
  12. KLASTERSKY J, 1986, AM J MED, V80, P2
  13. Kruger W, 1999, BONE MARROW TRANSPL, V23, P589, DOI 10.1038/sj.bmt.1701614
  14. Laws HJ, 2006, J HOSP INFECT, V62, P80, DOI 10.1016/j.jhin.2005.05.010
  15. Ley BE, 1998, EUR J CLIN MICROBIOL, V17, P247, DOI 10.1007/BF01699981
  16. Litzow MR, 2010, BLOOD, V115, P1850, DOI 10.1182/blood-2009-10-249128
  17. Marena C, 2001, INFECT CONT HOSP EP, V22, P510, DOI 10.1086/501942
  18. Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496
  19. Maschmeyer G, 2000, EUR J CLIN MICROBIOL, V19, P915, DOI 10.1007/s100960000410
  20. Nusair A, 2008, INFECT CONT HOSP EP, V29, P424, DOI 10.1086/587188
  21. Oliveira AL, 2007, BONE MARROW TRANSPL, V39, P775, DOI 10.1038/sj.bmt.1705677
  22. Paez J, 2011, J HOSP INFECT, V77, P76, DOI 10.1016/j.jhin.2010.08.007
  23. Ramphal R, 2004, CLIN INFECT DIS, V39, P25, DOI 10.1086/383048
  24. Schlesinger A, 2009, LANCET INFECT DIS, V9, P97, DOI 10.1016/S1473-3099(08)70284-6
  25. Tomblyn M, 2009, BONE MARROW TRANSPL, V44, P453, DOI 10.1038/bmt.2009.254
  26. Toscano CM, 2009, AM J INFECT CONTROL, V37, P327, DOI 10.1016/j.ajic.2008.01.012
  27. von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/48
Artigos e Materiais de Revistas Científicas - LIM/54